Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
1.030
+0.047 (4.76%)
At close: Nov 26, 2025, 4:00 PM EST
0.8855
-0.1450 (-14.03%)
Pre-market: Nov 28, 2025, 7:12 AM EST
Tilray Brands Revenue
Tilray Brands had revenue of $209.50M in the quarter ending August 31, 2025, with 4.73% growth. This brings the company's revenue in the last twelve months to $830.77M, up 2.31% year-over-year. In the fiscal year ending May 31, 2025, Tilray Brands had annual revenue of $821.31M with 4.10% growth.
Revenue (ttm)
$830.77M
Revenue Growth
+2.31%
P/S Ratio
1.16
Revenue / Employee
$292,317
Employees
2,842
Market Cap
1.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 821.31M | 32.37M | 4.10% |
| May 31, 2024 | 788.94M | 161.82M | 25.80% |
| May 31, 2023 | 627.12M | -1.25M | -0.20% |
| May 31, 2022 | 628.37M | 115.29M | 22.47% |
| May 31, 2021 | 513.09M | 107.76M | 26.59% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TLRY News
- 21 hours ago - Top reasons Tilray stock price has more downside to go - Invezz
- 1 day ago - Tilray Brands Announces Implementation of Previously Approved 1-for-10 Reverse Stock Split - GlobeNewsWire
- 4 days ago - Tilray Unveils Good Supply Vapes in Québec Following the Recent Introduction of Vape Products in Québec - GlobeNewsWire
- 7 days ago - Tilray Brands Stock Has Rallied 110% in Just 6 Months. Can Its Rally Keep Going? - The Motley Fool
- 9 days ago - Three Canadian Cannabis Stocks Worth Watching This Week - MarijuanaStocks
- 10 days ago - Tilray Brands Publishes New Investor Presentation Highlighting Leadership Across Beverage, Cannabis and Wellness Industries, Showcasing Its Global Growth Strategy and Transformation into a Diversified CPG Powerhouse Shaping the Future of Consumer Products - GlobeNewsWire
- 10 days ago - Here's why the Tilray stock price has crashed and what next - Invezz
- 12 days ago - Investing in Cannabis: Three Leading Stocks to Watch This November - MarijuanaStocks